Truxt Investmentos Ltda. acquired a new position in Waldencast plc (NASDAQ:WALD – Get Rating) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 5,000,000 shares of the company's stock, valued at approximately $50,000,000. Waldencast makes up 9.8% of Truxt Investmentos Ltda.'s holdings, making the stock its 2nd largest holding. Truxt Investmentos Ltda. owned 4.65% of Waldencast as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in WALD. UBS Group AG raised its position in Waldencast by 295.8% during the first quarter. UBS Group AG now owns 3,297 shares of the company's stock valued at $33,000 after purchasing an additional 2,464 shares in the last quarter. Penserra Capital Management LLC purchased a new stake in Waldencast during the first quarter valued at about $43,000. Exos Asset Management LLC purchased a new stake in Waldencast during the second quarter valued at about $347,000. Jane Street Group LLC purchased a new stake in Waldencast during the second quarter valued at about $353,000. Finally, Virtu Financial LLC purchased a new stake in Waldencast during the second quarter valued at about $391,000. Hedge funds and other institutional investors own 18.80% of the company's stock.
Get Waldencast alerts:Analyst Upgrades and Downgrades
Separately, DA Davidson lifted their price objective on Waldencast from $12.00 to $15.50 and gave the stock a "buy" rating in a report on Thursday, November 17th.
Waldencast Trading Down 1.3 %
WALD opened at $8.88 on Friday. The business's 50-day moving average price is $9.41 and its 200-day moving average price is $9.10. Waldencast plc has a 12 month low of $6.56 and a 12 month high of $12.10.Waldencast Profile
(Get Rating)
Waldencast plc, a skincare company, develops, markets, and sells skin health products worldwide. The company offers approximately 200 cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Further Reading
- Get a free copy of the StockNews.com research report on Waldencast (WALD)
- MarketBeat: Week in Review 01/09-01/13
- JPMorgan Chase Falls As Banks Brace For Recession
- Why is the Bed Bath & Beyond Stock Price up 261%?
- Roku Stock Price is Trending, Here's Why
- Carvana Stock Rally, Here's What You Need to Know
Want to see what other hedge funds are holding WALD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waldencast plc (NASDAQ:WALD – Get Rating).
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.